nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—CYP2B6—Simvastatin—atherosclerosis	0.0407	0.0619	CbGbCtD
Nicardipine—CYP3A5—Rosuvastatin—atherosclerosis	0.0345	0.0524	CbGbCtD
Nicardipine—CYP3A5—Simvastatin—atherosclerosis	0.032	0.0487	CbGbCtD
Nicardipine—CYP3A5—Pravastatin—atherosclerosis	0.0313	0.0477	CbGbCtD
Nicardipine—CYP3A5—Lovastatin—atherosclerosis	0.0313	0.0477	CbGbCtD
Nicardipine—CYP2C8—Simvastatin—atherosclerosis	0.0308	0.0469	CbGbCtD
Nicardipine—CYP2C8—Pravastatin—atherosclerosis	0.0301	0.0459	CbGbCtD
Nicardipine—CYP2C8—Lovastatin—atherosclerosis	0.0301	0.0459	CbGbCtD
Nicardipine—CYP2C19—Rosuvastatin—atherosclerosis	0.0278	0.0423	CbGbCtD
Nicardipine—CYP2C19—Simvastatin—atherosclerosis	0.0258	0.0393	CbGbCtD
Nicardipine—CYP2C19—Lovastatin—atherosclerosis	0.0253	0.0385	CbGbCtD
Nicardipine—CYP2D6—Niacin—atherosclerosis	0.0248	0.0378	CbGbCtD
Nicardipine—CYP2C9—Rosuvastatin—atherosclerosis	0.0231	0.0352	CbGbCtD
Nicardipine—ABCB1—Ezetimibe—atherosclerosis	0.0224	0.0341	CbGbCtD
Nicardipine—CYP2C9—Simvastatin—atherosclerosis	0.0215	0.0327	CbGbCtD
Nicardipine—CYP2C9—Pravastatin—atherosclerosis	0.021	0.032	CbGbCtD
Nicardipine—CYP2C9—Lovastatin—atherosclerosis	0.021	0.032	CbGbCtD
Nicardipine—ABCB1—Simvastatin—atherosclerosis	0.0208	0.0317	CbGbCtD
Nicardipine—ABCB1—Lovastatin—atherosclerosis	0.0204	0.031	CbGbCtD
Nicardipine—ABCB1—Pravastatin—atherosclerosis	0.0204	0.031	CbGbCtD
Nicardipine—CYP2D6—Simvastatin—atherosclerosis	0.0196	0.0299	CbGbCtD
Nicardipine—CYP2D6—Pravastatin—atherosclerosis	0.0192	0.0293	CbGbCtD
Nicardipine—CYP2D6—Lovastatin—atherosclerosis	0.0192	0.0293	CbGbCtD
Nicardipine—CYP3A4—Rosuvastatin—atherosclerosis	0.0134	0.0204	CbGbCtD
Nicardipine—CYP3A4—Ezetimibe—atherosclerosis	0.0134	0.0204	CbGbCtD
Nicardipine—CYP3A4—Simvastatin—atherosclerosis	0.0125	0.019	CbGbCtD
Nicardipine—CYP3A4—Pravastatin—atherosclerosis	0.0122	0.0186	CbGbCtD
Nicardipine—CYP3A4—Lovastatin—atherosclerosis	0.0122	0.0186	CbGbCtD
Nicardipine—Hypertonia—Rosuvastatin—atherosclerosis	0.00172	0.0122	CcSEcCtD
Nicardipine—Neck pain—Ezetimibe—atherosclerosis	0.00165	0.0117	CcSEcCtD
Nicardipine—Nocturia—Pravastatin—atherosclerosis	0.00152	0.0107	CcSEcCtD
Nicardipine—Nimodipine—AHR—atherosclerosis	0.00138	1	CrCbGaD
Nicardipine—Urine output increased—Niacin—atherosclerosis	0.00129	0.00913	CcSEcCtD
Nicardipine—CALM2—artery—atherosclerosis	0.00127	0.0464	CbGeAlD
Nicardipine—Hot flush—Ezetimibe—atherosclerosis	0.00127	0.00895	CcSEcCtD
Nicardipine—CALM1—artery—atherosclerosis	0.00126	0.0462	CbGeAlD
Nicardipine—Menopausal symptoms—Ezetimibe—atherosclerosis	0.00126	0.00887	CcSEcCtD
Nicardipine—Hypertonia—Niacin—atherosclerosis	0.00125	0.00885	CcSEcCtD
Nicardipine—Abnormal vision—Niacin—atherosclerosis	0.00125	0.00881	CcSEcCtD
Nicardipine—Atrial fibrillation—Simvastatin—atherosclerosis	0.00119	0.00842	CcSEcCtD
Nicardipine—PDE1B—adipose tissue—atherosclerosis	0.00118	0.0433	CbGeAlD
Nicardipine—Polyuria—Niacin—atherosclerosis	0.00118	0.00835	CcSEcCtD
Nicardipine—PDE1A—cardiovascular system—atherosclerosis	0.00113	0.0412	CbGeAlD
Nicardipine—Atrial fibrillation—Niacin—atherosclerosis	0.00109	0.00774	CcSEcCtD
Nicardipine—Hot flush—Pravastatin—atherosclerosis	0.00109	0.00772	CcSEcCtD
Nicardipine—Menopausal symptoms—Pravastatin—atherosclerosis	0.00108	0.00765	CcSEcCtD
Nicardipine—CALM2—endothelium—atherosclerosis	0.00107	0.0392	CbGeAlD
Nicardipine—CALM1—endothelium—atherosclerosis	0.00107	0.039	CbGeAlD
Nicardipine—Haematuria—Rosuvastatin—atherosclerosis	0.00105	0.0074	CcSEcCtD
Nicardipine—Sinusitis—Rosuvastatin—atherosclerosis	0.00103	0.00728	CcSEcCtD
Nicardipine—Face oedema—Niacin—atherosclerosis	0.001	0.00708	CcSEcCtD
Nicardipine—PDE1A—adipose tissue—atherosclerosis	0.000992	0.0363	CbGeAlD
Nicardipine—Rhinitis—Rosuvastatin—atherosclerosis	0.000988	0.00698	CcSEcCtD
Nicardipine—CALM2—blood vessel—atherosclerosis	0.000987	0.0361	CbGeAlD
Nicardipine—CALM1—blood vessel—atherosclerosis	0.000982	0.036	CbGeAlD
Nicardipine—Erectile dysfunction—Lovastatin—atherosclerosis	0.000961	0.00679	CcSEcCtD
Nicardipine—Orthostatic hypotension—Niacin—atherosclerosis	0.000947	0.00669	CcSEcCtD
Nicardipine—Erectile dysfunction—Ezetimibe—atherosclerosis	0.000943	0.00666	CcSEcCtD
Nicardipine—Erectile dysfunction—Simvastatin—atherosclerosis	0.000899	0.00635	CcSEcCtD
Nicardipine—Angina pectoris—Niacin—atherosclerosis	0.000873	0.00617	CcSEcCtD
Nicardipine—Sinusitis—Lovastatin—atherosclerosis	0.000873	0.00617	CcSEcCtD
Nicardipine—Sweating increased—Pravastatin—atherosclerosis	0.00086	0.00608	CcSEcCtD
Nicardipine—Angina pectoris—Pravastatin—atherosclerosis	0.00086	0.00608	CcSEcCtD
Nicardipine—Sinusitis—Ezetimibe—atherosclerosis	0.000856	0.00605	CcSEcCtD
Nicardipine—CACNB2—cardiovascular system—atherosclerosis	0.00083	0.0304	CbGeAlD
Nicardipine—Erectile dysfunction—Niacin—atherosclerosis	0.000826	0.00583	CcSEcCtD
Nicardipine—Sinusitis—Simvastatin—atherosclerosis	0.000817	0.00577	CcSEcCtD
Nicardipine—Erectile dysfunction—Pravastatin—atherosclerosis	0.000813	0.00575	CcSEcCtD
Nicardipine—Oedema peripheral—Ezetimibe—atherosclerosis	0.000807	0.0057	CcSEcCtD
Nicardipine—CACNA2D1—cardiovascular system—atherosclerosis	0.000779	0.0285	CbGeAlD
Nicardipine—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000776	0.00548	CcSEcCtD
Nicardipine—Flushing—Lovastatin—atherosclerosis	0.000775	0.00548	CcSEcCtD
Nicardipine—Myocardial infarction—Pravastatin—atherosclerosis	0.000772	0.00545	CcSEcCtD
Nicardipine—CACNA1C—connective tissue—atherosclerosis	0.000769	0.0282	CbGeAlD
Nicardipine—Sweating—Niacin—atherosclerosis	0.000766	0.00542	CcSEcCtD
Nicardipine—Flushing—Ezetimibe—atherosclerosis	0.000761	0.00537	CcSEcCtD
Nicardipine—Sinusitis—Pravastatin—atherosclerosis	0.000738	0.00522	CcSEcCtD
Nicardipine—Arthralgia—Rosuvastatin—atherosclerosis	0.000731	0.00516	CcSEcCtD
Nicardipine—Myalgia—Rosuvastatin—atherosclerosis	0.000731	0.00516	CcSEcCtD
Nicardipine—Flushing—Simvastatin—atherosclerosis	0.000725	0.00513	CcSEcCtD
Nicardipine—CACNA1D—cardiovascular system—atherosclerosis	0.000725	0.0265	CbGeAlD
Nicardipine—Rhinitis—Niacin—atherosclerosis	0.000719	0.00508	CcSEcCtD
Nicardipine—Hypoaesthesia—Niacin—atherosclerosis	0.000714	0.00505	CcSEcCtD
Nicardipine—Rhinitis—Pravastatin—atherosclerosis	0.000708	0.00501	CcSEcCtD
Nicardipine—Oedema peripheral—Niacin—atherosclerosis	0.000707	0.005	CcSEcCtD
Nicardipine—Confusional state—Rosuvastatin—atherosclerosis	0.000706	0.00499	CcSEcCtD
Nicardipine—Hypoaesthesia—Pravastatin—atherosclerosis	0.000703	0.00497	CcSEcCtD
Nicardipine—Infection—Rosuvastatin—atherosclerosis	0.000696	0.00492	CcSEcCtD
Nicardipine—PDE1A—liver—atherosclerosis	0.000696	0.0255	CbGeAlD
Nicardipine—Visual impairment—Niacin—atherosclerosis	0.000692	0.00489	CcSEcCtD
Nicardipine—CACNA2D1—adipose tissue—atherosclerosis	0.000687	0.0251	CbGeAlD
Nicardipine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000686	0.00485	CcSEcCtD
Nicardipine—Vision blurred—Lovastatin—atherosclerosis	0.000685	0.00484	CcSEcCtD
Nicardipine—Tremor—Lovastatin—atherosclerosis	0.000681	0.00482	CcSEcCtD
Nicardipine—Visual impairment—Pravastatin—atherosclerosis	0.000681	0.00481	CcSEcCtD
Nicardipine—Ill-defined disorder—Lovastatin—atherosclerosis	0.000675	0.00477	CcSEcCtD
Nicardipine—CACNA1C—cardiovascular system—atherosclerosis	0.000669	0.0245	CbGeAlD
Nicardipine—Tinnitus—Niacin—atherosclerosis	0.000669	0.00473	CcSEcCtD
Nicardipine—Flushing—Niacin—atherosclerosis	0.000666	0.00471	CcSEcCtD
Nicardipine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000662	0.00468	CcSEcCtD
Nicardipine—Tinnitus—Pravastatin—atherosclerosis	0.000659	0.00466	CcSEcCtD
Nicardipine—Malaise—Lovastatin—atherosclerosis	0.000656	0.00463	CcSEcCtD
Nicardipine—Flushing—Pravastatin—atherosclerosis	0.000656	0.00463	CcSEcCtD
Nicardipine—Vertigo—Lovastatin—atherosclerosis	0.000653	0.00462	CcSEcCtD
Nicardipine—Malaise—Ezetimibe—atherosclerosis	0.000643	0.00455	CcSEcCtD
Nicardipine—Vision blurred—Simvastatin—atherosclerosis	0.000641	0.00453	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000638	0.00451	CcSEcCtD
Nicardipine—Tremor—Simvastatin—atherosclerosis	0.000637	0.0045	CcSEcCtD
Nicardipine—Insomnia—Rosuvastatin—atherosclerosis	0.000634	0.00448	CcSEcCtD
Nicardipine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000631	0.00446	CcSEcCtD
Nicardipine—Palpitations—Ezetimibe—atherosclerosis	0.00063	0.00445	CcSEcCtD
Nicardipine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000629	0.00444	CcSEcCtD
Nicardipine—Arthralgia—Lovastatin—atherosclerosis	0.000619	0.00438	CcSEcCtD
Nicardipine—Chest pain—Lovastatin—atherosclerosis	0.000619	0.00438	CcSEcCtD
Nicardipine—Myalgia—Lovastatin—atherosclerosis	0.000619	0.00438	CcSEcCtD
Nicardipine—Anxiety—Lovastatin—atherosclerosis	0.000617	0.00436	CcSEcCtD
Nicardipine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000617	0.00436	CcSEcCtD
Nicardipine—Hypertension—Ezetimibe—atherosclerosis	0.000616	0.00435	CcSEcCtD
Nicardipine—Malaise—Simvastatin—atherosclerosis	0.000614	0.00434	CcSEcCtD
Nicardipine—Tension—Niacin—atherosclerosis	0.000613	0.00433	CcSEcCtD
Nicardipine—Discomfort—Lovastatin—atherosclerosis	0.000612	0.00432	CcSEcCtD
Nicardipine—Vertigo—Simvastatin—atherosclerosis	0.000611	0.00432	CcSEcCtD
Nicardipine—Arthralgia—Ezetimibe—atherosclerosis	0.000607	0.00429	CcSEcCtD
Nicardipine—Chest pain—Ezetimibe—atherosclerosis	0.000607	0.00429	CcSEcCtD
Nicardipine—Myalgia—Ezetimibe—atherosclerosis	0.000607	0.00429	CcSEcCtD
Nicardipine—Nervousness—Niacin—atherosclerosis	0.000607	0.00429	CcSEcCtD
Nicardipine—Dry mouth—Lovastatin—atherosclerosis	0.000606	0.00428	CcSEcCtD
Nicardipine—Tension—Pravastatin—atherosclerosis	0.000604	0.00427	CcSEcCtD
Nicardipine—Discomfort—Ezetimibe—atherosclerosis	0.0006	0.00424	CcSEcCtD
Nicardipine—Constipation—Rosuvastatin—atherosclerosis	0.000599	0.00423	CcSEcCtD
Nicardipine—Pain—Rosuvastatin—atherosclerosis	0.000599	0.00423	CcSEcCtD
Nicardipine—Confusional state—Lovastatin—atherosclerosis	0.000599	0.00423	CcSEcCtD
Nicardipine—Nervousness—Pravastatin—atherosclerosis	0.000597	0.00422	CcSEcCtD
Nicardipine—Dry mouth—Ezetimibe—atherosclerosis	0.000594	0.0042	CcSEcCtD
Nicardipine—CACNA1C—adipose tissue—atherosclerosis	0.00059	0.0216	CbGeAlD
Nicardipine—Infection—Lovastatin—atherosclerosis	0.00059	0.00417	CcSEcCtD
Nicardipine—Vision blurred—Niacin—atherosclerosis	0.000589	0.00416	CcSEcCtD
Nicardipine—Confusional state—Ezetimibe—atherosclerosis	0.000587	0.00415	CcSEcCtD
Nicardipine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000581	0.00411	CcSEcCtD
Nicardipine—Vision blurred—Pravastatin—atherosclerosis	0.00058	0.0041	CcSEcCtD
Nicardipine—Chest pain—Simvastatin—atherosclerosis	0.000579	0.00409	CcSEcCtD
Nicardipine—Arthralgia—Simvastatin—atherosclerosis	0.000579	0.00409	CcSEcCtD
Nicardipine—Myalgia—Simvastatin—atherosclerosis	0.000579	0.00409	CcSEcCtD
Nicardipine—Infection—Ezetimibe—atherosclerosis	0.000578	0.00409	CcSEcCtD
Nicardipine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000577	0.00408	CcSEcCtD
Nicardipine—Anxiety—Simvastatin—atherosclerosis	0.000577	0.00408	CcSEcCtD
Nicardipine—Tremor—Pravastatin—atherosclerosis	0.000576	0.00407	CcSEcCtD
Nicardipine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000573	0.00405	CcSEcCtD
Nicardipine—Discomfort—Simvastatin—atherosclerosis	0.000572	0.00404	CcSEcCtD
Nicardipine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000571	0.00403	CcSEcCtD
Nicardipine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00057	0.00403	CcSEcCtD
Nicardipine—Vertigo—Niacin—atherosclerosis	0.000561	0.00397	CcSEcCtD
Nicardipine—Syncope—Niacin—atherosclerosis	0.00056	0.00396	CcSEcCtD
Nicardipine—Confusional state—Simvastatin—atherosclerosis	0.00056	0.00396	CcSEcCtD
Nicardipine—Oedema—Simvastatin—atherosclerosis	0.000555	0.00392	CcSEcCtD
Nicardipine—Malaise—Pravastatin—atherosclerosis	0.000555	0.00392	CcSEcCtD
Nicardipine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000554	0.00391	CcSEcCtD
Nicardipine—Vertigo—Pravastatin—atherosclerosis	0.000553	0.0039	CcSEcCtD
Nicardipine—CHRM2—cardiovascular system—atherosclerosis	0.000552	0.0202	CbGeAlD
Nicardipine—Palpitations—Niacin—atherosclerosis	0.000552	0.0039	CcSEcCtD
Nicardipine—Infection—Simvastatin—atherosclerosis	0.000552	0.0039	CcSEcCtD
Nicardipine—Loss of consciousness—Niacin—atherosclerosis	0.000549	0.00388	CcSEcCtD
Nicardipine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000544	0.00384	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000541	0.00382	CcSEcCtD
Nicardipine—Insomnia—Lovastatin—atherosclerosis	0.000537	0.00379	CcSEcCtD
Nicardipine—Paraesthesia—Lovastatin—atherosclerosis	0.000533	0.00377	CcSEcCtD
Nicardipine—Arthralgia—Niacin—atherosclerosis	0.000532	0.00376	CcSEcCtD
Nicardipine—Myalgia—Niacin—atherosclerosis	0.000532	0.00376	CcSEcCtD
Nicardipine—Hypertension—Pravastatin—atherosclerosis	0.000531	0.00375	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00053	0.00375	CcSEcCtD
Nicardipine—Dyspnoea—Lovastatin—atherosclerosis	0.000529	0.00374	CcSEcCtD
Nicardipine—Insomnia—Ezetimibe—atherosclerosis	0.000527	0.00372	CcSEcCtD
Nicardipine—Arthralgia—Pravastatin—atherosclerosis	0.000524	0.0037	CcSEcCtD
Nicardipine—Myalgia—Pravastatin—atherosclerosis	0.000524	0.0037	CcSEcCtD
Nicardipine—Chest pain—Pravastatin—atherosclerosis	0.000524	0.0037	CcSEcCtD
Nicardipine—Paraesthesia—Ezetimibe—atherosclerosis	0.000523	0.00369	CcSEcCtD
Nicardipine—Dyspepsia—Lovastatin—atherosclerosis	0.000523	0.00369	CcSEcCtD
Nicardipine—Anxiety—Pravastatin—atherosclerosis	0.000522	0.00369	CcSEcCtD
Nicardipine—Dry mouth—Niacin—atherosclerosis	0.00052	0.00368	CcSEcCtD
Nicardipine—Dyspnoea—Ezetimibe—atherosclerosis	0.000519	0.00367	CcSEcCtD
Nicardipine—Discomfort—Pravastatin—atherosclerosis	0.000517	0.00366	CcSEcCtD
Nicardipine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000516	0.00365	CcSEcCtD
Nicardipine—CACNB2—liver—atherosclerosis	0.000513	0.0188	CbGeAlD
Nicardipine—Dyspepsia—Ezetimibe—atherosclerosis	0.000513	0.00362	CcSEcCtD
Nicardipine—Oedema—Niacin—atherosclerosis	0.00051	0.0036	CcSEcCtD
Nicardipine—Constipation—Lovastatin—atherosclerosis	0.000508	0.00359	CcSEcCtD
Nicardipine—Pain—Lovastatin—atherosclerosis	0.000508	0.00359	CcSEcCtD
Nicardipine—Confusional state—Pravastatin—atherosclerosis	0.000506	0.00358	CcSEcCtD
Nicardipine—CALM2—connective tissue—atherosclerosis	0.000506	0.0185	CbGeAlD
Nicardipine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000506	0.00357	CcSEcCtD
Nicardipine—CALM1—connective tissue—atherosclerosis	0.000504	0.0184	CbGeAlD
Nicardipine—CHRM1—cardiovascular system—atherosclerosis	0.000503	0.0184	CbGeAlD
Nicardipine—Asthenia—Rosuvastatin—atherosclerosis	0.000503	0.00355	CcSEcCtD
Nicardipine—Insomnia—Simvastatin—atherosclerosis	0.000502	0.00355	CcSEcCtD
Nicardipine—Oedema—Pravastatin—atherosclerosis	0.000502	0.00355	CcSEcCtD
Nicardipine—Shock—Niacin—atherosclerosis	0.000502	0.00354	CcSEcCtD
Nicardipine—Infection—Pravastatin—atherosclerosis	0.000499	0.00352	CcSEcCtD
Nicardipine—Paraesthesia—Simvastatin—atherosclerosis	0.000499	0.00352	CcSEcCtD
Nicardipine—Constipation—Ezetimibe—atherosclerosis	0.000498	0.00352	CcSEcCtD
Nicardipine—Pain—Ezetimibe—atherosclerosis	0.000498	0.00352	CcSEcCtD
Nicardipine—Tachycardia—Niacin—atherosclerosis	0.000498	0.00352	CcSEcCtD
Nicardipine—Dyspnoea—Simvastatin—atherosclerosis	0.000495	0.0035	CcSEcCtD
Nicardipine—CALM3—adipose tissue—atherosclerosis	0.000494	0.0181	CbGeAlD
Nicardipine—Hyperhidrosis—Niacin—atherosclerosis	0.000493	0.00348	CcSEcCtD
Nicardipine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000491	0.00347	CcSEcCtD
Nicardipine—Feeling abnormal—Lovastatin—atherosclerosis	0.000489	0.00346	CcSEcCtD
Nicardipine—Dyspepsia—Simvastatin—atherosclerosis	0.000489	0.00345	CcSEcCtD
Nicardipine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000485	0.00343	CcSEcCtD
Nicardipine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000485	0.00343	CcSEcCtD
Nicardipine—CACNA2D1—liver—atherosclerosis	0.000482	0.0176	CbGeAlD
Nicardipine—Feeling abnormal—Ezetimibe—atherosclerosis	0.00048	0.00339	CcSEcCtD
Nicardipine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000479	0.00339	CcSEcCtD
Nicardipine—Hypotension—Niacin—atherosclerosis	0.000476	0.00337	CcSEcCtD
Nicardipine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000476	0.00336	CcSEcCtD
Nicardipine—Pain—Simvastatin—atherosclerosis	0.000475	0.00336	CcSEcCtD
Nicardipine—Constipation—Simvastatin—atherosclerosis	0.000475	0.00336	CcSEcCtD
Nicardipine—Body temperature increased—Lovastatin—atherosclerosis	0.000469	0.00332	CcSEcCtD
Nicardipine—Abdominal pain—Lovastatin—atherosclerosis	0.000469	0.00332	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000464	0.00328	CcSEcCtD
Nicardipine—Dizziness—Rosuvastatin—atherosclerosis	0.000463	0.00327	CcSEcCtD
Nicardipine—Insomnia—Niacin—atherosclerosis	0.000461	0.00326	CcSEcCtD
Nicardipine—Abdominal pain—Ezetimibe—atherosclerosis	0.00046	0.00325	CcSEcCtD
Nicardipine—Body temperature increased—Ezetimibe—atherosclerosis	0.00046	0.00325	CcSEcCtD
Nicardipine—Paraesthesia—Niacin—atherosclerosis	0.000458	0.00323	CcSEcCtD
Nicardipine—Feeling abnormal—Simvastatin—atherosclerosis	0.000458	0.00323	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000457	0.00323	CcSEcCtD
Nicardipine—Dyspnoea—Niacin—atherosclerosis	0.000455	0.00321	CcSEcCtD
Nicardipine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000454	0.00321	CcSEcCtD
Nicardipine—Insomnia—Pravastatin—atherosclerosis	0.000454	0.00321	CcSEcCtD
Nicardipine—Somnolence—Niacin—atherosclerosis	0.000453	0.0032	CcSEcCtD
Nicardipine—Paraesthesia—Pravastatin—atherosclerosis	0.000451	0.00319	CcSEcCtD
Nicardipine—Dyspepsia—Niacin—atherosclerosis	0.000449	0.00317	CcSEcCtD
Nicardipine—CACNA1D—liver—atherosclerosis	0.000448	0.0164	CbGeAlD
Nicardipine—Dyspnoea—Pravastatin—atherosclerosis	0.000448	0.00316	CcSEcCtD
Nicardipine—Dyspepsia—Pravastatin—atherosclerosis	0.000442	0.00312	CcSEcCtD
Nicardipine—Rash—Rosuvastatin—atherosclerosis	0.000442	0.00312	CcSEcCtD
Nicardipine—Dermatitis—Rosuvastatin—atherosclerosis	0.000441	0.00312	CcSEcCtD
Nicardipine—CALM2—cardiovascular system—atherosclerosis	0.00044	0.0161	CbGeAlD
Nicardipine—Abdominal pain—Simvastatin—atherosclerosis	0.000439	0.0031	CcSEcCtD
Nicardipine—Body temperature increased—Simvastatin—atherosclerosis	0.000439	0.0031	CcSEcCtD
Nicardipine—Headache—Rosuvastatin—atherosclerosis	0.000439	0.0031	CcSEcCtD
Nicardipine—CALM1—cardiovascular system—atherosclerosis	0.000438	0.016	CbGeAlD
Nicardipine—Hypersensitivity—Lovastatin—atherosclerosis	0.000437	0.00309	CcSEcCtD
Nicardipine—Pain—Niacin—atherosclerosis	0.000436	0.00308	CcSEcCtD
Nicardipine—Pain—Pravastatin—atherosclerosis	0.000429	0.00303	CcSEcCtD
Nicardipine—Constipation—Pravastatin—atherosclerosis	0.000429	0.00303	CcSEcCtD
Nicardipine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000429	0.00303	CcSEcCtD
Nicardipine—Asthenia—Lovastatin—atherosclerosis	0.000426	0.00301	CcSEcCtD
Nicardipine—Asthenia—Ezetimibe—atherosclerosis	0.000418	0.00295	CcSEcCtD
Nicardipine—Gastrointestinal pain—Niacin—atherosclerosis	0.000417	0.00295	CcSEcCtD
Nicardipine—Nausea—Rosuvastatin—atherosclerosis	0.000416	0.00294	CcSEcCtD
Nicardipine—Feeling abnormal—Pravastatin—atherosclerosis	0.000414	0.00292	CcSEcCtD
Nicardipine—ADRA1A—cardiovascular system—atherosclerosis	0.000413	0.0151	CbGeAlD
Nicardipine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00041	0.0029	CcSEcCtD
Nicardipine—Hypersensitivity—Simvastatin—atherosclerosis	0.000409	0.00289	CcSEcCtD
Nicardipine—Diarrhoea—Lovastatin—atherosclerosis	0.000406	0.00287	CcSEcCtD
Nicardipine—Body temperature increased—Niacin—atherosclerosis	0.000403	0.00285	CcSEcCtD
Nicardipine—Abdominal pain—Niacin—atherosclerosis	0.000403	0.00285	CcSEcCtD
Nicardipine—Asthenia—Simvastatin—atherosclerosis	0.000398	0.00282	CcSEcCtD
Nicardipine—Diarrhoea—Ezetimibe—atherosclerosis	0.000398	0.00282	CcSEcCtD
Nicardipine—Abdominal pain—Pravastatin—atherosclerosis	0.000397	0.0028	CcSEcCtD
Nicardipine—Body temperature increased—Pravastatin—atherosclerosis	0.000397	0.0028	CcSEcCtD
Nicardipine—CHRM3—adipose tissue—atherosclerosis	0.000397	0.0145	CbGeAlD
Nicardipine—Dizziness—Lovastatin—atherosclerosis	0.000393	0.00277	CcSEcCtD
Nicardipine—ABCB1—blood vessel—atherosclerosis	0.000392	0.0144	CbGeAlD
Nicardipine—CALM2—adipose tissue—atherosclerosis	0.000388	0.0142	CbGeAlD
Nicardipine—CALM1—adipose tissue—atherosclerosis	0.000386	0.0141	CbGeAlD
Nicardipine—Dizziness—Ezetimibe—atherosclerosis	0.000385	0.00272	CcSEcCtD
Nicardipine—Diarrhoea—Simvastatin—atherosclerosis	0.00038	0.00268	CcSEcCtD
Nicardipine—Vomiting—Lovastatin—atherosclerosis	0.000377	0.00267	CcSEcCtD
Nicardipine—Hypersensitivity—Niacin—atherosclerosis	0.000376	0.00265	CcSEcCtD
Nicardipine—Rash—Lovastatin—atherosclerosis	0.000374	0.00264	CcSEcCtD
Nicardipine—Dermatitis—Lovastatin—atherosclerosis	0.000374	0.00264	CcSEcCtD
Nicardipine—Headache—Lovastatin—atherosclerosis	0.000372	0.00263	CcSEcCtD
Nicardipine—Vomiting—Ezetimibe—atherosclerosis	0.00037	0.00262	CcSEcCtD
Nicardipine—Hypersensitivity—Pravastatin—atherosclerosis	0.00037	0.00261	CcSEcCtD
Nicardipine—Dizziness—Simvastatin—atherosclerosis	0.000367	0.00259	CcSEcCtD
Nicardipine—Rash—Ezetimibe—atherosclerosis	0.000367	0.00259	CcSEcCtD
Nicardipine—Dermatitis—Ezetimibe—atherosclerosis	0.000367	0.00259	CcSEcCtD
Nicardipine—Asthenia—Niacin—atherosclerosis	0.000366	0.00258	CcSEcCtD
Nicardipine—Headache—Ezetimibe—atherosclerosis	0.000365	0.00258	CcSEcCtD
Nicardipine—ADRA1A—adipose tissue—atherosclerosis	0.000364	0.0133	CbGeAlD
Nicardipine—Asthenia—Pravastatin—atherosclerosis	0.00036	0.00255	CcSEcCtD
Nicardipine—Vomiting—Simvastatin—atherosclerosis	0.000353	0.00249	CcSEcCtD
Nicardipine—Nausea—Lovastatin—atherosclerosis	0.000353	0.00249	CcSEcCtD
Nicardipine—Rash—Simvastatin—atherosclerosis	0.00035	0.00247	CcSEcCtD
Nicardipine—Dermatitis—Simvastatin—atherosclerosis	0.00035	0.00247	CcSEcCtD
Nicardipine—Diarrhoea—Niacin—atherosclerosis	0.000349	0.00246	CcSEcCtD
Nicardipine—Headache—Simvastatin—atherosclerosis	0.000348	0.00246	CcSEcCtD
Nicardipine—CALM3—liver—atherosclerosis	0.000347	0.0127	CbGeAlD
Nicardipine—Nausea—Ezetimibe—atherosclerosis	0.000346	0.00244	CcSEcCtD
Nicardipine—Diarrhoea—Pravastatin—atherosclerosis	0.000343	0.00243	CcSEcCtD
Nicardipine—Dizziness—Niacin—atherosclerosis	0.000337	0.00238	CcSEcCtD
Nicardipine—Dizziness—Pravastatin—atherosclerosis	0.000332	0.00235	CcSEcCtD
Nicardipine—Nausea—Simvastatin—atherosclerosis	0.00033	0.00233	CcSEcCtD
Nicardipine—CYP2B6—cardiovascular system—atherosclerosis	0.000327	0.012	CbGeAlD
Nicardipine—Vomiting—Niacin—atherosclerosis	0.000324	0.00229	CcSEcCtD
Nicardipine—CYP2C9—cardiovascular system—atherosclerosis	0.000324	0.0119	CbGeAlD
Nicardipine—Rash—Niacin—atherosclerosis	0.000321	0.00227	CcSEcCtD
Nicardipine—Dermatitis—Niacin—atherosclerosis	0.000321	0.00227	CcSEcCtD
Nicardipine—Headache—Niacin—atherosclerosis	0.000319	0.00226	CcSEcCtD
Nicardipine—Vomiting—Pravastatin—atherosclerosis	0.000319	0.00226	CcSEcCtD
Nicardipine—Rash—Pravastatin—atherosclerosis	0.000317	0.00224	CcSEcCtD
Nicardipine—Dermatitis—Pravastatin—atherosclerosis	0.000316	0.00223	CcSEcCtD
Nicardipine—Headache—Pravastatin—atherosclerosis	0.000314	0.00222	CcSEcCtD
Nicardipine—CYP2E1—cardiovascular system—atherosclerosis	0.000307	0.0112	CbGeAlD
Nicardipine—Nausea—Niacin—atherosclerosis	0.000303	0.00214	CcSEcCtD
Nicardipine—Nausea—Pravastatin—atherosclerosis	0.000298	0.00211	CcSEcCtD
Nicardipine—CYP3A5—adipose tissue—atherosclerosis	0.00029	0.0106	CbGeAlD
Nicardipine—CALM2—liver—atherosclerosis	0.000272	0.00997	CbGeAlD
Nicardipine—CALM1—liver—atherosclerosis	0.000271	0.00992	CbGeAlD
Nicardipine—CYP2C19—liver—atherosclerosis	0.000259	0.00946	CbGeAlD
Nicardipine—ADRA1A—liver—atherosclerosis	0.000255	0.00935	CbGeAlD
Nicardipine—CYP2C8—liver—atherosclerosis	0.000226	0.00826	CbGeAlD
Nicardipine—CYP3A5—liver—atherosclerosis	0.000204	0.00745	CbGeAlD
Nicardipine—CYP2B6—liver—atherosclerosis	0.000202	0.00741	CbGeAlD
Nicardipine—CYP2C9—liver—atherosclerosis	0.0002	0.00734	CbGeAlD
Nicardipine—CYP2E1—liver—atherosclerosis	0.00019	0.00695	CbGeAlD
Nicardipine—ABCB1—cardiovascular system—atherosclerosis	0.000175	0.0064	CbGeAlD
Nicardipine—ABCB1—adipose tissue—atherosclerosis	0.000154	0.00565	CbGeAlD
Nicardipine—CYP3A4—liver—atherosclerosis	0.000153	0.00559	CbGeAlD
Nicardipine—CYP2D6—liver—atherosclerosis	0.00015	0.00551	CbGeAlD
Nicardipine—ABCB1—liver—atherosclerosis	0.000108	0.00396	CbGeAlD
Nicardipine—CYP2C9—Metabolism—PPARA—atherosclerosis	3.8e-06	2.2e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—NFKB1—atherosclerosis	3.79e-06	2.19e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—NFKB1—atherosclerosis	3.79e-06	2.19e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—INS—atherosclerosis	3.78e-06	2.19e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—NOS3—atherosclerosis	3.77e-06	2.18e-05	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—AKT1—atherosclerosis	3.77e-06	2.18e-05	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—AKT1—atherosclerosis	3.77e-06	2.18e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	3.76e-06	2.18e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CXCL8—atherosclerosis	3.76e-06	2.18e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—TGFB1—atherosclerosis	3.75e-06	2.17e-05	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—AKT1—atherosclerosis	3.74e-06	2.16e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—MAPK8—atherosclerosis	3.72e-06	2.16e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—MAPK8—atherosclerosis	3.72e-06	2.16e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PIK3CG—atherosclerosis	3.72e-06	2.15e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PIK3CG—atherosclerosis	3.72e-06	2.15e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—AGT—atherosclerosis	3.71e-06	2.15e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—MAPK3—atherosclerosis	3.7e-06	2.14e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—AKT1—atherosclerosis	3.7e-06	2.14e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—NOS3—atherosclerosis	3.69e-06	2.14e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—NOS3—atherosclerosis	3.69e-06	2.14e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—MAPK3—atherosclerosis	3.68e-06	2.13e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—AGT—atherosclerosis	3.68e-06	2.13e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—VEGFA—atherosclerosis	3.68e-06	2.13e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—STAT3—atherosclerosis	3.64e-06	2.11e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—INS—atherosclerosis	3.64e-06	2.11e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—APOE—atherosclerosis	3.64e-06	2.11e-05	CbGpPWpGaD
Nicardipine—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	3.63e-06	2.1e-05	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—AKT1—atherosclerosis	3.62e-06	2.09e-05	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—AKT1—atherosclerosis	3.62e-06	2.09e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ABCA1—atherosclerosis	3.61e-06	2.09e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—APOE—atherosclerosis	3.6e-06	2.09e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—CAV1—atherosclerosis	3.6e-06	2.09e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—APOA1—atherosclerosis	3.59e-06	2.08e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TGFB1—atherosclerosis	3.59e-06	2.08e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PTGS2—atherosclerosis	3.58e-06	2.08e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CCL2—atherosclerosis	3.58e-06	2.07e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	3.57e-06	2.07e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—CAV1—atherosclerosis	3.57e-06	2.07e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	3.57e-06	2.07e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—APOA1—atherosclerosis	3.56e-06	2.06e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—MAPK3—atherosclerosis	3.56e-06	2.06e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—MAPK3—atherosclerosis	3.56e-06	2.06e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—STAT3—atherosclerosis	3.52e-06	2.04e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—INS—atherosclerosis	3.52e-06	2.04e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—INS—atherosclerosis	3.52e-06	2.04e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IGF1—atherosclerosis	3.52e-06	2.04e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PTGS2—atherosclerosis	3.51e-06	2.03e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PTGS2—atherosclerosis	3.5e-06	2.03e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PTGS2—atherosclerosis	3.49e-06	2.02e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3CG—atherosclerosis	3.48e-06	2.02e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—MAPK3—atherosclerosis	3.48e-06	2.01e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—ALB—atherosclerosis	3.47e-06	2.01e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CCL2—atherosclerosis	3.46e-06	2e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CCL2—atherosclerosis	3.46e-06	2e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PPARG—atherosclerosis	3.44e-06	1.99e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—STAT3—atherosclerosis	3.4e-06	1.97e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—STAT3—atherosclerosis	3.4e-06	1.97e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IGF1—atherosclerosis	3.4e-06	1.97e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IGF1—atherosclerosis	3.4e-06	1.97e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	3.4e-06	1.97e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	3.39e-06	1.96e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	3.38e-06	1.96e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—INS—atherosclerosis	3.38e-06	1.96e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PTGS2—atherosclerosis	3.37e-06	1.95e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PTGS2—atherosclerosis	3.37e-06	1.95e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TGFB1—atherosclerosis	3.37e-06	1.95e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	3.36e-06	1.95e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—MAPK3—atherosclerosis	3.36e-06	1.95e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PPARG—atherosclerosis	3.36e-06	1.95e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	3.35e-06	1.94e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—SERPINE1—atherosclerosis	3.34e-06	1.93e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	3.34e-06	1.93e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—NOS3—atherosclerosis	3.32e-06	1.92e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	3.3e-06	1.91e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—INS—atherosclerosis	3.3e-06	1.91e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	3.3e-06	1.91e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	3.28e-06	1.9e-05	CbGpPWpGaD
Nicardipine—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	3.27e-06	1.9e-05	CbGpPWpGaD
Nicardipine—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	3.26e-06	1.89e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CG—atherosclerosis	3.25e-06	1.88e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—MAPK3—atherosclerosis	3.25e-06	1.88e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—MAPK3—atherosclerosis	3.25e-06	1.88e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—STAT3—atherosclerosis	3.25e-06	1.88e-05	CbGpPWpGaD
Nicardipine—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	3.23e-06	1.87e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—SERPINE1—atherosclerosis	3.23e-06	1.87e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—SERPINE1—atherosclerosis	3.23e-06	1.87e-05	CbGpPWpGaD
Nicardipine—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	3.22e-06	1.87e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—IL6—atherosclerosis	3.22e-06	1.87e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—IL6—atherosclerosis	3.21e-06	1.86e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—NOS3—atherosclerosis	3.19e-06	1.85e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—IL6—atherosclerosis	3.18e-06	1.84e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	3.17e-06	1.84e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PPARG—atherosclerosis	3.17e-06	1.83e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—STAT3—atherosclerosis	3.14e-06	1.82e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—STAT3—atherosclerosis	3.14e-06	1.82e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PPARG—atherosclerosis	3.14e-06	1.82e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—INS—atherosclerosis	3.11e-06	1.8e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—MAPK3—atherosclerosis	3.1e-06	1.8e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.1e-06	1.8e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—ALB—atherosclerosis	3.1e-06	1.79e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—NOS3—atherosclerosis	3.08e-06	1.79e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—NOS3—atherosclerosis	3.08e-06	1.79e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—INS—atherosclerosis	3.08e-06	1.78e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MMP9—atherosclerosis	3.07e-06	1.78e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MMP9—atherosclerosis	3.06e-06	1.77e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	3.05e-06	1.77e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PTGS2—atherosclerosis	3.03e-06	1.76e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	3.03e-06	1.76e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MMP9—atherosclerosis	3.03e-06	1.75e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	3.02e-06	1.75e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—ALB—atherosclerosis	3.02e-06	1.75e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	3.02e-06	1.75e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	3.02e-06	1.75e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—TGFB1—atherosclerosis	3.01e-06	1.74e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—MAPK3—atherosclerosis	3e-06	1.74e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—MAPK3—atherosclerosis	3e-06	1.74e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	2.99e-06	1.73e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	2.99e-06	1.73e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	2.98e-06	1.73e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	2.97e-06	1.72e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	2.97e-06	1.72e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—APOB—atherosclerosis	2.97e-06	1.72e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	2.96e-06	1.72e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—NOS3—atherosclerosis	2.96e-06	1.71e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	2.94e-06	1.7e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	2.94e-06	1.7e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	2.94e-06	1.7e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	2.93e-06	1.69e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—TGFB1—atherosclerosis	2.91e-06	1.69e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—TGFB1—atherosclerosis	2.91e-06	1.69e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—NOS3—atherosclerosis	2.89e-06	1.67e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.89e-06	1.67e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	2.89e-06	1.67e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—ALB—atherosclerosis	2.85e-06	1.65e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—LPL—atherosclerosis	2.84e-06	1.64e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CXCL8—atherosclerosis	2.83e-06	1.64e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—IL6—atherosclerosis	2.82e-06	1.64e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—ALB—atherosclerosis	2.82e-06	1.63e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	2.8e-06	1.62e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GPX1—atherosclerosis	2.77e-06	1.6e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	2.75e-06	1.59e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	2.74e-06	1.59e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CXCL8—atherosclerosis	2.74e-06	1.58e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CXCL8—atherosclerosis	2.74e-06	1.58e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—STAT3—atherosclerosis	2.73e-06	1.58e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—NOS3—atherosclerosis	2.72e-06	1.58e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	2.72e-06	1.57e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—STAT3—atherosclerosis	2.72e-06	1.57e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	2.71e-06	1.57e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTGS2—atherosclerosis	2.71e-06	1.57e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—IL6—atherosclerosis	2.7e-06	1.57e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—NOS3—atherosclerosis	2.7e-06	1.56e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CD36—atherosclerosis	2.69e-06	1.56e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—STAT3—atherosclerosis	2.69e-06	1.56e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—IL6—atherosclerosis	2.69e-06	1.56e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	2.68e-06	1.55e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTGS2—atherosclerosis	2.64e-06	1.53e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—AKT1—atherosclerosis	2.6e-06	1.51e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	2.6e-06	1.51e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—IL6—atherosclerosis	2.6e-06	1.51e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—IL6—atherosclerosis	2.6e-06	1.51e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	2.6e-06	1.5e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	2.57e-06	1.49e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	2.56e-06	1.48e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MMP9—atherosclerosis	2.56e-06	1.48e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.55e-06	1.48e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—IL6—atherosclerosis	2.54e-06	1.47e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—NFKB1—atherosclerosis	2.53e-06	1.47e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	2.53e-06	1.46e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	2.52e-06	1.46e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PPARA—atherosclerosis	2.5e-06	1.45e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—AKT1—atherosclerosis	2.49e-06	1.44e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	2.49e-06	1.44e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTGS2—atherosclerosis	2.49e-06	1.44e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MAPK8—atherosclerosis	2.49e-06	1.44e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	2.49e-06	1.44e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—AKT1—atherosclerosis	2.48e-06	1.44e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MMP9—atherosclerosis	2.47e-06	1.43e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MMP9—atherosclerosis	2.47e-06	1.43e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTGS2—atherosclerosis	2.47e-06	1.43e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL6—atherosclerosis	2.46e-06	1.42e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—NFKB1—atherosclerosis	2.45e-06	1.42e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—NFKB1—atherosclerosis	2.45e-06	1.42e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—AGT—atherosclerosis	2.43e-06	1.4e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MAPK8—atherosclerosis	2.41e-06	1.39e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MAPK8—atherosclerosis	2.41e-06	1.39e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—AKT1—atherosclerosis	2.4e-06	1.39e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—AKT1—atherosclerosis	2.4e-06	1.39e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL6—atherosclerosis	2.38e-06	1.38e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL6—atherosclerosis	2.38e-06	1.38e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—APOE—atherosclerosis	2.38e-06	1.38e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CAV1—atherosclerosis	2.36e-06	1.36e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—APOA1—atherosclerosis	2.35e-06	1.36e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—AKT1—atherosclerosis	2.35e-06	1.36e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—VEGFA—atherosclerosis	2.3e-06	1.33e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—STAT3—atherosclerosis	2.27e-06	1.32e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—IL6—atherosclerosis	2.27e-06	1.31e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—AKT1—atherosclerosis	2.27e-06	1.31e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—VEGFA—atherosclerosis	2.22e-06	1.29e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—VEGFA—atherosclerosis	2.22e-06	1.29e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—STAT3—atherosclerosis	2.2e-06	1.27e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—STAT3—atherosclerosis	2.2e-06	1.27e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—IL6—atherosclerosis	2.19e-06	1.27e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—IL6—atherosclerosis	2.19e-06	1.27e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—AKT1—atherosclerosis	2.19e-06	1.27e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—AKT1—atherosclerosis	2.19e-06	1.27e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MAPK3—atherosclerosis	2.17e-06	1.26e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.15e-06	1.24e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IL6—atherosclerosis	2.11e-06	1.22e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TGFB1—atherosclerosis	2.11e-06	1.22e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MAPK3—atherosclerosis	2.1e-06	1.22e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MAPK3—atherosclerosis	2.1e-06	1.22e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—AKT1—atherosclerosis	2.09e-06	1.21e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—AKT1—atherosclerosis	2.09e-06	1.21e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PPARG—atherosclerosis	2.07e-06	1.2e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TGFB1—atherosclerosis	2.04e-06	1.18e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TGFB1—atherosclerosis	2.04e-06	1.18e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—INS—atherosclerosis	2.03e-06	1.18e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—AKT1—atherosclerosis	2.02e-06	1.17e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—AKT1—atherosclerosis	2.02e-06	1.17e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	1.95e-06	1.13e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IL6—atherosclerosis	1.9e-06	1.1e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IL6—atherosclerosis	1.9e-06	1.1e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IL6—atherosclerosis	1.88e-06	1.09e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IL6—atherosclerosis	1.87e-06	1.09e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ALB—atherosclerosis	1.86e-06	1.08e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—AKT1—atherosclerosis	1.8e-06	1.04e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—NOS3—atherosclerosis	1.78e-06	1.03e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—AKT1—atherosclerosis	1.76e-06	1.02e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—AKT1—atherosclerosis	1.76e-06	1.02e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—AKT1—atherosclerosis	1.76e-06	1.02e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—AKT1—atherosclerosis	1.75e-06	1.02e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—AKT1—atherosclerosis	1.75e-06	1.01e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—AKT1—atherosclerosis	1.73e-06	1e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	1.73e-06	1e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—AKT1—atherosclerosis	1.7e-06	9.82e-06	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—AKT1—atherosclerosis	1.7e-06	9.82e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.63e-06	9.43e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL6—atherosclerosis	1.59e-06	9.2e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL6—atherosclerosis	1.54e-06	8.9e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL6—atherosclerosis	1.54e-06	8.9e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—AKT1—atherosclerosis	1.53e-06	8.83e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—AKT1—atherosclerosis	1.47e-06	8.49e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—AKT1—atherosclerosis	1.42e-06	8.21e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—AKT1—atherosclerosis	1.42e-06	8.21e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—AKT1—atherosclerosis	1.36e-06	7.88e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—AKT1—atherosclerosis	1.33e-06	7.69e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—AKT1—atherosclerosis	1.25e-06	7.25e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—AKT1—atherosclerosis	1.24e-06	7.19e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—AKT1—atherosclerosis	8.19e-07	4.74e-06	CbGpPWpGaD
